The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia. [electronic resource]
Producer: 20151109Description: 2008-21 p. digitalISSN:- 1879-0852
- Acid Anhydride Hydrolases -- genetics
- Adenine Nucleotides -- pharmacology
- Antimetabolites, Antineoplastic -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Arabinonucleosides -- pharmacology
- Cell Line, Tumor
- Cell Survival -- drug effects
- Clofarabine
- Cytarabine -- pharmacology
- DNA Methylation
- Dose-Response Relationship, Drug
- Drug Synergism
- Epigenesis, Genetic
- Gene Expression Regulation, Neoplastic
- Gene Rearrangement
- Histone-Lysine N-Methyltransferase -- genetics
- Humans
- Infant
- Inhibitory Concentration 50
- Myeloid-Lymphoid Leukemia Protein -- genetics
- Neoplasm Proteins -- genetics
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- diagnosis
- Promoter Regions, Genetic
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.